This has important ramifications for treatment of acute promyelocytic leukemias caused by a chromosomal translocation fusing the PML and RARA (retinoic acid receptor alpha) genes, and most patients can be cured by combination therapy involving arsenic and retinoic acid20. This evidence concerns the gene RARA and acute promyelocytic leukemia.